(LRN) Stride - Overview
Sector: Consumer Defensive | Industry: Education & Training Services | Exchange: NYSE (USA) | Market Cap: 3.769m USD | Total Return: -41.7% in 12m
Avg Turnover: 48.3M
EPS Trend: 99.2%
Qual. Beats: 0
Rev. Trend: 99.4%
Qual. Beats: 0
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
Stride, Inc. (LRN) provides technology-based education services and online curricula for K-12 students and adult learners. The company operates through two primary segments: General Education, which supports virtual and blended public schools, and Career Learning, which focuses on skills-based training in healthcare, IT, and business through brands like Galvanize and MedCerts.
The business model relies on a proprietary software ecosystem that integrates enrollment, instruction, and progress tracking for public school districts and private institutions. This approach capitalizes on the growing shift toward digitized learning, a sector where revenue is often driven by per-pupil funding from state and local governments.
Beyond K-12 education, Stride has expanded into post-secondary professional development and corporate staffing services. Examining the historical financial trends on ValueRay can help clarify how these diversified segments contribute to the companys overall margin stability.
Headquartered in Reston, Virginia, the firm rebranded from K12 Inc. in 2020 to reflect its broader focus on lifelong career readiness and adult vocational training.
- Rising enrollment in career learning programs diversifies revenue beyond K-12 schooling
- State funding levels for virtual public schools dictate core revenue growth
- Expansion of adult learner brands MedCerts and Tech Elevator improves margins
- Legislative shifts in school choice policies impact total addressable market size
- Higher student retention rates reduce customer acquisition costs and boost profitability
| Net Income: 308.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 4.23 > 1.0 |
| NWC/Revenue: 58.19% < 20% (prev 54.40%; Δ 3.80% < -1%) |
| CFO/TA 0.18 > 3% & CFO 429.4m > Net Income 308.1m |
| Net Debt (-128.6m) to EBITDA (535.7m): -0.24 < 3 |
| Current Ratio: 6.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (47.6m) vs 12m ago -3.20% < -2% |
| Gross Margin: 38.34% > 18% (prev 0.39%; Δ 3.80k% > 0.5%) |
| Asset Turnover: 108.9% > 50% (prev 103.5%; Δ 5.42% > 0%) |
| Interest Coverage Ratio: 35.63 > 6 (EBITDA TTM 535.7m / Interest Expense TTM 11.6m) |
| A: 0.60 (Total Current Assets 1.76b - Total Current Liabilities 283.2m) / Total Assets 2.45b |
| B: 0.45 (Retained Earnings 1.10b / Total Assets 2.45b) |
| C: 0.18 (EBIT TTM 412.8m / Avg Total Assets 2.33b) |
| D: 1.37 (Book Value of Equity 1.10b / Total Liabilities 805.0m) |
| Altman-Z'' = 8.06 = AAA |
| DSRI: 1.10 (Receivables 854.9m/699.8m, Revenue 2.54b/2.29b) |
| GMI: 1.02 (GM 38.34% / 39.08%) |
| AQI: 0.93 (AQ_t 0.24 / AQ_t-1 0.25) |
| SGI: 1.11 (Revenue 2.54b / 2.29b) |
| TATA: -0.05 (NI 308.1m - CFO 429.4m) / TA 2.45b) |
| Beneish M = -2.94 (Cap -4..+1) = A |
As of May 27, 2026, the stock is trading at USD 89.48 with a total of 277,600 shares traded.
Over the past week, the price has changed by -0.38%,
over one month by -8.50%,
over three months by +4.22% and
over the past year by -41.67%.
Stride has received a consensus analysts rating of 4.17. Therefore, it is recommended to buy LRN.
- StrongBuy: 2
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 113.5 | 26.8% |
P/E Trailing = 13.8701
P/E Forward = 9.9602
P/S = 1.4864
P/B = 2.2955
P/EG = 0.4979
Revenue TTM = 2.54b USD
EBIT TTM = 412.8m USD
EBITDA TTM = 535.7m USD
Long Term Debt = 417.6m USD (from longTermDebt, last quarter)
Short Term Debt = 61.7m USD (from shortTermDebt, last quarter)
Debt = 677.3m USD (from shortLongTermDebtTotal, last quarter) + Leases 129.8m
Net Debt = -128.6m USD (calculated: Debt 677.3m - CCE 805.8m)
Enterprise Value = 3.64b USD (3.77b + Debt 677.3m - CCE 805.8m)
Interest Coverage Ratio = 35.63 (Ebit TTM 412.8m / Interest Expense TTM 11.6m)
EV/FCF = 9.71x (Enterprise Value 3.64b / FCF TTM 374.8m)
FCF Yield = 10.30% (FCF TTM 374.8m / Enterprise Value 3.64b)
FCF Margin = 14.78% (FCF TTM 374.8m / Revenue TTM 2.54b)
Net Margin = 12.15% (Net Income TTM 308.1m / Revenue TTM 2.54b)
Gross Margin = 38.34% ((Revenue TTM 2.54b - Cost of Revenue TTM 1.56b) / Revenue TTM)
Gross Margin QoQ = 36.76% (prev 41.13%)
Tobins Q-Ratio = 1.49 (Enterprise Value 3.64b / Total Assets 2.45b)
Interest Expense / Debt = 1.71% (Interest Expense 11.6m / Debt 677.3m)
Taxrate = 26.27% (31.5m / 120.1m)
NOPAT = 304.3m (EBIT 412.8m * (1 - 26.27%))
Current Ratio = 6.21 (Total Current Assets 1.76b / Total Current Liabilities 283.2m)
Debt / Equity = 0.41 (Debt 677.3m / totalStockholderEquity, last quarter 1.64b)
Debt / EBITDA = -0.24 (Net Debt -128.6m / EBITDA 535.7m)
Debt / FCF = -0.34 (Net Debt -128.6m / FCF TTM 374.8m)
Total Stockholder Equity = 1.55b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.24% (Net Income 308.1m / Total Assets 2.45b)
RoE = 19.89% (Net Income TTM 308.1m / Total Stockholder Equity 1.55b)
RoCE = 20.99% (EBIT 412.8m / Capital Employed (Equity 1.55b + L.T.Debt 417.6m))
RoIC = 13.67% (NOPAT 304.3m / Invested Capital 2.23b)
WACC = 4.13% (E(3.77b)/V(4.45b) * Re(4.65%) + D(677.3m)/V(4.45b) * Rd(1.71%) * (1-Tc(0.26)))
Discount Rate = 4.65% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 60.0 | Cagr: 4.13%
[DCF] Terminal Value 77.97% ; FCFF base≈322.8m ; Y1≈370.1m ; Y5≈544.6m
[DCF] Fair Price = 195.7 (EV 8.20b - Net Debt -128.6m = Equity 8.32b / Shares 42.5m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 99.22 | EPS CAGR: 47.49% | SUE: 0.34 | # QB: 0
Revenue Correlation: 99.36 | Revenue CAGR: 13.66% | SUE: 0.01 | # QB: 0
EPS next Quarter (2026-09-30): EPS=1.50 | Chg30d=+6.38% | Revisions=+20% | Analysts=1
EPS current Year (2026-06-30): EPS=8.20 | Chg30d=+0.33% | Revisions=+43% | GrowthEPS=+1.2% | GrowthRev=+4.3%
EPS next Year (2027-06-30): EPS=8.76 | Chg30d=-1.24% | Revisions=-33% | GrowthEPS=+6.8% | GrowthRev=+4.5%
[Analyst] Revisions Ratio: +43%